IGM Art Gallery's "Creating A Healthy Life" Forum For Dr. Howard Murad's book: "Water Secret" please visit: http://www.amazon.com/gp/aw/d/0470554703 For a copy of Dr. Rishi Manchanda's new good "Upstream Doc... By: IGM Art Gallery … Continue reading →

Newswise Case Western Reserve University is part of a landmark study that has discovered four novel gene variations associated with blood pressure. The 19-site meta-analysis, involving nearly 30,000 African-Americans, also found that the set of genetic mutations are also associated with blood pressure across other populations. Epidemiology and biostatistics professor Xiaofeng Zhu, PhD, is co-senior author of the paper, which appears in The American Journal of Human Genetics. The Continental Origins and Genetic Epidemiology Network (COGENT) consortium conducted the research, which is the largest genome-wide association study of blood pressure in individuals of African ancestry. Most gene discovery studies to date have been performed using individuals of European ancestry. Previous genome-wide association studies using samples from individuals of African descent failed to detect any replicable genes associated with blood pressure. In addition to their disproportionate suffering, hypertension occurs earlier in life for African-Americans compared to individuals of other ancestries, Zhu explained. Therefore, it is important to study this population to better understand genetic susceptibility to hypertension. Zhu and his colleagues also confirmed that previous findings regarding other genes whose presence correlates with increased hypertension risk. Although it is unknown how the genes regulate blood pressure, Zhu added, our findings contribute … Continue reading →

SAN CARLOS, CALIFORNIA and TORONTO, ONTARIO--(Marketwired - Sep 11, 2013) - Natera, a leading innovator in prenatal genetic testing, and LifeLabs Medical Laboratory Services (LifeLabs), a Canadian company with over 50 years' experience in laboratory testing and management, today announced a distribution partnership for Natera's non-invasive prenatal screening test, Panorama. Panorama was launched in March 2013 for the detection of trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome) and select sex chromosome abnormalities, such as monosomy X (Turner syndrome). The detection of triploidy was added in August 2013. "There is tremendous demand by patients for non-invasive prenatal testing, and we are pleased to be able to offer these tests at our laboratories in Canada," said Dr. Doug Tkachuk, Chief Medical and Quality Officer at LifeLabs. "We are especially glad to be partnering with Natera to give patients access to Panorama, which we believe offers the best data possible across most indications." "We continue to gain momentum with our global rollout by partnering with leading organizations, such as LifeLabs, and are glad to now expand into Canada," said Matthew Rabinowitz, Ph.D., Chief Executive Officer of Natera. "We look forward to bringing patients access to the most accurate … Continue reading →

Sep. 11, 2013 The largest DNA-sequencing study of anorexia nervosa has linked the eating disorder to variants in a gene coding for an enzyme that regulates cholesterol metabolism. The finding suggests that anorexia could be caused in part by a disruption in the normal processing of cholesterol, which may disrupt mood and eating behavior. "These findings point in a direction that probably no one would have considered taking before," said Nicholas J. Schork, a professor at The Scripps Research Institute (TSRI). Schork was the senior investigator for the multicenter study, which was published recently online ahead of print in the journal Molecular Psychiatry. Anorexia affects up to 1 percent of women, and has an estimated mortality rate of 10 or more percent, making it perhaps the deadliest of psychiatric illnesses. Anorexics severely restrict eating and become emaciated, yet see themselves as fat. Individuals with anorexia nervosa tend to be perfectionistic, anxious or depressed, and obsessive, said Walter Kaye, a co-author on the study, professor at the University of California (UC), San Diego School of Medicine and principal investigator of the Price Foundation Genetic Studies of Anorexia Nervosa. How the disorder develops is still not fully understood. Anorexia predominantly affects girls … Continue reading →

Public release date: 10-Sep-2013 [ | E-mail | Share ] Contact: Jessica Studeny Jessica.studeny@case.edu 216-368-4692 Case Western Reserve University Case Western Reserve University is part of a landmark study that has discovered four novel gene variations which are associated with blood pressure. The 19-site meta-analysis, involving nearly 30,000 African-Americans, also found that the set of genetic mutations are also associated with blood pressure across other populations. Epidemiology and biostatistics professor Xiaofeng Zhu, PhD, is co-senior author of the paper, which appears in The American Journal of Human Genetics. The Continental Origins and Genetic Epidemiology Network (COGENT) consortium conducted the research, which is the largest genome-wide association study of blood pressure in individuals of African ancestry. Most gene discovery studies to date have been performed using individuals of European ancestry. Previous genome-wide association studies using samples from individuals of African descent failed to detect any replicable genes associated with blood pressure. "In addition to their disproportionate suffering, hypertension occurs earlier in life for African-Americans compared to individuals of other ancestries," Zhu explained. "Therefore, it is important to study this population to better understand genetic susceptibility to hypertension." Zhu and his colleagues also confirmed that previous findings regarding other genes whose presence … Continue reading →

Freeport, The Bahamas (PRWEB) September 10, 2013 Okyanos Heart Institute, whose mission it is to bring a new standard of care and better quality of life to patients with coronary artery disease using cardiac stem cell therapy, has announced that it is a gold sponsor of the International Stem Cell Society (STEMSO) Global Conference to be held at the Grand Lucayan Resort in Freeport, Grand Bahamas, February 19-22, 2014. The conference, titled Bridging the Gap: Research to Point of Care, brings together medical scientists and clinicians to discuss progress in the field of research and clinical protocols. The topics will include ethical considerations and regulatory panel discussions specifically focused on navigating the newly proposed Bahamas legislation. Many practitioners know very little about the topic of stem cell therapy because it has been a research topic and not a standard of care, said Howard Walpole, M.D., M.B.A., F.A.C.C., F.S.C.A.I. and chief medical officer for Okyanos Heart Institute. However, with the most recent research, trials and clinical applications that are ongoing, the field is progressing. I believe there will be new treatments adopted for a number of diseases in the very near future. Bringing together the experts from these various disciplines to … Continue reading →

Orange, CA (PRWEB) September 11, 2013 The top stem cell therapy clinic in Orange County, TeleHealth, is now offering PRP therapy for degenerative arthritis and soft tissue injuries. The treatment is covered by insurance and represents an excellent method of repairing and regenerating injured tissue rather than simply masking pain. For more information and scheduling, call (888) 828-4575. PRP therapy has recently become extremely popular in orthopedics and pain management due to multiple studies showing its benefit. One of these studies out of Hospital for Special Surgery showed the treatment relieved knee pain long term from degenerative arthritis and also helped preserve knee cartilage. TeleHealth offers platelet rich plasma therapy as an outpatient service, and the stem cell therapy clinic accepts most major medical insurances along with Medicare, Workers Compensation and Personal Injury liens. The PRP therapy has very low risk because it involves taking blood from the patient, processing it, and then injecting it into the problem area. The PRP then calls in the body's stem cells for repair and regeneration. In addition to PRP therapy, TeleHealth also offers stem cell injection therapy with bone marrow derived stem cell injection treatment and fat derived as well. These treatments are … Continue reading →

In a bid to expand presence in the cell therapy space, Novartis (NVS) recently announced that it has entered into a global licensing and research collaboration agreement with privately-held biopharmaceutical company, Regenerex. As per the agreement, Novartis will gain access to Regenerexs proprietary stem cell based therapy platform Facilitating Cell Therapy (FCRx) which is being evaluated for kidney transplantation. The stem cell based therapy aims to induce stable immunological tolerance in kidney transplantation. Additionally, FCRx can also be evaluated for the treatment of serious genetic deficiencies such as inherited metabolic storage disorders and hemoglobinopathies. The addition of FCRx will expand Novartis existing cell therapy portfolio which already has two cell therapy platforms - HSC835 and CTL019. Both are being evaluated for hematological malignancies. While HSC835 is being evaluated in patients with high-risk hematological malignancies in a phase I study, CTL019 is being developed in a phase II study for the treatment of acute lymphoblastic leukemia and chronic lymphocytic leukemia. We note that apart from stem cell therapy based treatments, Novartis also markets a drug - Glivec, which is approved for the treatment of ALL and chronic myeloid leukemia. We remind investors that other companies which are developing cell based therapies … Continue reading →